BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11

• Press Releases

  Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026

  March 9, 2026

   · 

  1 min read
• Press Releases

  Zevra Reports Fourth Quarter and Full Year 2025 Financial Results

  March 9, 2026

   · 

  18 min read
• Press Releases

  Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update

  March 9, 2026

   · 

  12 min read
• Press Releases

  Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results

  March 9, 2026

   · 

  10 min read
• Press Releases

  Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates

  March 9, 2026

   · 

  8 min read
• Press Releases

  Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4) - March 9, 2026

  March 9, 2026

   · 

  4 min read
• Press Releases

  C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 9, 2026

  March 9, 2026

   · 

  1 min read
• Press Releases

  Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

  March 9, 2026

   · 

  16 min read
• Press Releases

  Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results

  March 9, 2026

   · 

  10 min read
• Press Releases

  MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures

  March 9, 2026

   · 

  11 min read